|
🐜
|
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
47 auth.
J. Smolen,
R. Landewé,
J. Bijlsma,
G. Burmester,
M. Dougados,
A. Kerschbaumer,
I. McInnes,
A. Sepriano,
R. V. van Vollenhoven,
M. D. de Wit,
D. Aletaha,
M. Aringer,
J. Askling,
A. Balsa,
M. Boers,
...
A. D. den Broeder,
M. Buch,
F. Buttgereit,
R. Caporali,
M. Cardiel,
D. De Cock,
C. Codreanu,
M. Cutolo,
C. Edwards,
Y. van Eijk-Hustings,
P. Emery,
A. Finckh,
L. Gossec,
J. Gottenberg,
M. Hetland,
T. Huizinga,
Marios Koloumas,
Zhanguo Li,
X. Mariette,
U. Müller-Ladner,
E. Mysler,
J. D. da Silva,
G. Poór,
J. Pope,
A. Rubbert-Roth,
A. Ruyssen-witrand,
K. Saag,
A. Strangfeld,
T. Takeuchi,
M. Voshaar,
R. Westhovens,
D. M. van der Heijde
|
10 |
2020 |
10
🐜
|
|
🐜
|
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
48 auth.
J. Smolen,
R. Landewé,
S. Bergstra,
A. Kerschbaumer,
A. Sepriano,
D. Aletaha,
R. Caporali,
C. Edwards,
K. Hyrich,
J. Pope,
Savia de Souza,
T. Stamm,
T. Takeuchi,
P. Verschueren,
K. Winthrop,
...
A. Balsa,
J. Bathon,
M. Buch,
G. Burmester,
F. Buttgereit,
M. Cardiel,
K. Chatzidionysiou,
C. Codreanu,
M. Cutolo,
A. D. den Broeder,
K. El Aoufy,
A. Finckh,
J. Fonseca,
J. Gottenberg,
E. Haavardsholm,
A. Iagnocco,
K. Lauper,
Zhanguo Li,
I. McInnes,
E. Mysler,
P. Nash,
G. Poór,
G. Ristić,
F. Rivellese,
A. Rubbert-Roth,
H. Schulze-Koops,
N. Stoilov,
Anja Strangfeld,
A. H. M. van der Helm-van Mil,
E. van Duuren,
T. V. Vliet Vlieland,
R. Westhovens,
D. M. van der Heijde
|
9 |
2022 |
9
🐜
|
|
🐜
|
Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial.
10 auth.
D. M. van der Heijde,
L. Klareskog,
V. Rodríguez-valverde,
C. Codreanu,
H. Bolosiu,
J. Melo-Gomes,
...
J. Tornero-Molina,
J. Wajdula,
R. Pedersen,
S. Fatenejad
|
9 |
2006 |
9
🐜
|
|
🐜
|
2016 update of the EULAR recommendations for the management of early arthritis
23 auth.
B. Combe,
R. Landewé,
C. Daien,
C. Hua,
D. Aletaha,
J. Álvaro-Gracia,
M. Bakkers,
N. Brodin,
G. Burmester,
C. Codreanu,
...
R. Conway,
M. Dougados,
P. Emery,
G. Ferraccioli,
J. Fonseca,
K. Raza,
L. Silva-Fernández,
J. Smolen,
D. Skingle,
Z. Szekanecz,
T. Kvien,
A. H. M. van der Helm-van Mil,
R. V. van Vollenhoven
|
8 |
2016 |
8
🐜
|
|
🐜
|
EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis
24 auth.
H. V. van Steenbergen,
D. Aletaha,
L. B. D. Beaart-van de Voorde,
E. Brouwer,
C. Codreanu,
B. Combe,
J. Fonseca,
M. Hetland,
F. Humby,
T. Kvien,
...
K. Niedermann,
L. Nuño,
S. Oliver,
S. Rantapää-Dahlqvist,
K. Raza,
D. van Schaardenburg,
G. Schett,
L. De Smet,
G. Szücs,
J. Vencovský,
P. Wiland,
M. D. de Wit,
R. Landewé,
A. H. M. van der Helm-van Mil
|
7 |
2016 |
7
🐜
|
|
🐜
|
Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis.
15 auth.
D. Heijde,
Lars Klareskog,
R. Landewé,
G. Bruyn,
A. Cantagrel,
P. Durez,
G. Herrero-Beaumont,
Y. Molad,
C. Codreanu,
G. Valentini,
...
R. Záhora,
R. Pedersen,
D. MacPeek,
J. Wajdula,
S. Fatenejad
|
7 |
2007 |
7
🐜
|
|
🐜
|
Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO results
8 auth.
D. Heijde,
Lars Klareskog,
M. Boers,
R. Landewé,
C. Codreanu,
H. Bolosiu,
...
R. Pedersen,
S. Fatenejad
|
7 |
2005 |
7
🐜
|
|
🐜
|
Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial
10 auth.
T. D. Villiers,
D. Kendler,
A. Chines,
P. Lips,
J. Kaufman,
A. B. Levine,
...
N. Mairon,
C. Codreanu,
D. Felsenberg,
Jacques P. Brown
|
7 |
2010 |
7
🐜
|
|
🐜
|
Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparison
11 auth.
B. Combe,
C. Codreanu,
U. Fiocco,
M. Gaubitz,
P. Geusens,
T. Kvien,
...
K. Pavelka,
P. Sambrook,
J. Smolen,
J. Wajdula,
S. Fatenejad
|
6 |
2006 |
6
🐜
|
|
🐜
|
Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial
9 auth.
D. Heijde,
Lars Klareskog,
A. Singh,
J. Tornero,
J. Melo-Gomes,
C. Codreanu,
...
R. Pedersen,
B. Freundlich,
S. Fatenejad
|
6 |
2005 |
6
🐜
|
|
🐜
|
The Link Between Inflammaging and Degenerative Joint Diseases
10 auth.
E. Rezuș,
A. Cardoneanu,
A. Burlui,
A. Luca,
C. Codreanu,
B. Tamba,
...
G. Stanciu,
N. Dima,
C. Bădescu,
C. Rezus
|
6 |
2019 |
6
🐜
|
|
🐜
|
Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the ‘JAK-pot’ collaboration
29 auth.
K. Lauper,
M. Iudici,
D. Mongin,
S. Bergstra,
D. Choquette,
C. Codreanu,
R. Cordtz,
D. De Cock,
L. Dreyer,
O. Elkayam,
E. Hauge,
D. Huschek,
K. Hyrich,
F. Iannone,
N. Inanç,
...
L. Kearsley‐Fleet,
E. Kristianslund,
T. Kvien,
B. Leeb,
G. Lukina,
D. Nordström,
K. Pavelka,
M. Pombo-Suárez,
Ž. Rotar,
M. Santos,
Anja Strangfeld,
P. Verschueren,
D. Courvoisier,
A. Finckh
|
6 |
2022 |
6
🐜
|
